Literature DB >> 4047982

Vasopressin and brain development: studies using the Brattleboro rat.

G J Boer.   

Abstract

Anomalies in hormonal and neurotransmitter status during early stages of brain development, can lead to lifespan alterations in the functioning of central systems. The neuropeptide vasopressin is nowadays recognized as a putative neurotransmitter, after years of study on its neurosecretory hormonal aspect in water metabolism. Since vasopressin is moreover present early in the brain, and has various mitogenic, metabolic and physiological actions, one might expect vasopressin to be of importance for normal brain development as well. Indeed, the absence of brain vasopressin in the Brattleboro mutant rat coincides with impaired brain development, and some physiological and behavioral defects of these rats are not adjusted by treatment with vasopressin. Regionally the cerebellum seems to be the most affected brain area, both morphologically and biochemically. Only when vasopressin supplementation was done prenatally, this disturbed growth could be restored, which suggests an early role for vasopressin in neurogenesis. Enhanced levels of vasopressin during the perinatal period on the other hand, have been shown to affect permanently the 'setting' of peripheral vasopressin functions in cardiovascular and renal regulatory systems. It is not excluded as yet that after such treatments central organization of vasopressin systems is not impaired as well.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4047982     DOI: 10.1016/0196-9781(85)90011-7

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  10 in total

1.  Developmental effects of vasotocin and nonapeptide receptors on early social attachment and affiliative behavior in the zebra finch.

Authors:  Nicole M Baran; Nathan C Sklar; Elizabeth Adkins-Regan
Journal:  Horm Behav       Date:  2015-10-23       Impact factor: 3.587

Review 2.  Developmental perspectives on oxytocin and vasopressin.

Authors:  Elizabeth A D Hammock
Journal:  Neuropsychopharmacology       Date:  2014-05-27       Impact factor: 7.853

3.  Perinatal exposure to octabromodiphenyl ether mixture, DE-79, alters the vasopressinergic system in adult rats.

Authors:  Mhar Y Alvarez-Gonzalez; Eduardo Sánchez-Islas; Samuel Mucio-Ramirez; Patricia de Gortari; María I Amaya; Prasada Rao S Kodavanti; Martha León-Olea
Journal:  Toxicol Appl Pharmacol       Date:  2020-02-04       Impact factor: 4.219

4.  Widespread alterations in central noradrenaline, dopamine, and serotonin systems in the Brattleboro rat not related to the local absence of vasopressin.

Authors:  M G Feenstra; F G Snijdewint; H Van Galen; G J Boer
Journal:  Neurochem Res       Date:  1990-03       Impact factor: 3.996

Review 5.  Neurohypophyseal peptides as regulators of growth and development. A review.

Authors:  D A Carter; C K Fai; D Murphy
Journal:  J Mol Neurosci       Date:  1993       Impact factor: 3.444

6.  Development of vasotocin pathways in the bullfrog brain.

Authors:  S K Boyd
Journal:  Cell Tissue Res       Date:  1994-06       Impact factor: 5.249

Review 7.  Neuropeptide growth factors and cancer.

Authors:  P J Woll
Journal:  Br J Cancer       Date:  1991-03       Impact factor: 7.640

Review 8.  Sensitive Periods, Vasotocin-Family Peptides, and the Evolution and Development of Social Behavior.

Authors:  Nicole M Baran
Journal:  Front Endocrinol (Lausanne)       Date:  2017-08-02       Impact factor: 5.555

9.  Atypical Social Development in Vasopressin-Deficient Brattleboro Rats.

Authors:  Matthew J Paul; Nicole V Peters; Mary K Holder; Anastasia M Kim; Jack Whylings; Joseph I Terranova; Geert J de Vries
Journal:  eNeuro       Date:  2016-04-06

10.  Early Life Manipulations of the Nonapeptide System Alter Pair Maintenance Behaviors and Neural Activity in Adult Male Zebra Finches.

Authors:  Nicole M Baran; Michelle L Tomaszycki; Elizabeth Adkins-Regan
Journal:  Front Behav Neurosci       Date:  2016-03-29       Impact factor: 3.558

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.